glp-1 gip 2ra and GLP‐1, the two incretin hormones: Similarities and differences GIPR/GLP-1R dual agonist therapies for

Even gradual dose escalation does not eliminate intolerance in every patient

People doing reasonably well on semaglutide but wondering whether newer drugs may offer more weight loss or better metabolic control

Another aspect that should be explored is the treatment effect in female rodents

Clinical data shows significant improvements in depression scores, anxiety measures, and overall quality of life assessments in people who achieve meaningful weight loss with GLP-1 therapy

But some that are being developed could be available to patients in the next couple of years

MariTide uses antibodies, and your body might produce anti-drug antibodies in response